CAMBRIDGE, Mass.--Eleven Biotherapeutics, Inc. (Nasdaq:EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results